Study title: An Open, Randomized Study of Efficacy, Safety, and Tolerability of Ivermectin Single Dose (One or Two Day Course) vs. Thiabendazole (Three-Day Course) in the Treatment of Patients Infected With Strongyloides Stercoralis
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Parasitic Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: IVERMECTIN | |||||
ATC code: P02CF01 | |||||
Document link: J17_020_ ivermectin.pdf | |||||
Document date: 2011-11-10 | |||||
Study number: J17_020 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |